These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33534976)

  • 1. Management of Antithrombotic Therapy after Acute Coronary Syndromes.
    Rodriguez F; Harrington RA
    N Engl J Med; 2021 Feb; 384(5):452-460. PubMed ID: 33534976
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombotic treatment in acute coronary syndrome].
    Darius H; Rupprecht HJ; Genth-Zotz S; Wittlinger T; Zotz R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S17-22. PubMed ID: 24446037
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic treatment in acute coronary syndromes.
    Hoole SP; Saw J
    Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy after Acute Coronary Syndromes. Reply.
    Rodriguez F; Harrington RA
    N Engl J Med; 2021 May; 384(19):1873-1874. PubMed ID: 33979504
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges in managing venous thromboembolism and acute coronary syndrome: case studies of the use of antithrombotic and antiplatelet therapies. Introduction.
    Haines ST
    Am J Health Syst Pharm; 2008 Aug; 65(15 Suppl 7):S3-4. PubMed ID: 18653823
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.
    Gurbel PA; Tantry US
    Heart; 2016 Jun; 102(11):882-92. PubMed ID: 26944654
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative Effects of Genetic and Nongenetic Factors in Antithrombotic Strategy.
    Nakahashi T; Sakata K; Tada H
    J Atheroscler Thromb; 2023 Dec; 30(12):1763-1765. PubMed ID: 37730374
    [No Abstract]   [Full Text] [Related]  

  • 8. [Path of exploration for the optimal antithrombotic treatment strategy for patients with coronary heart disease].
    Li Y; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):429-431. PubMed ID: 35589590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic drugs.
    Treat Guidel Med Lett; 2011 Oct; 9(110):61-6; quiz 2 p following 66. PubMed ID: 21941228
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation - Dual versus triple antithrombotic therapy.
    Collet JP; Thiele H
    Eur Heart J; 2021 May; 42(20):2020-2021. PubMed ID: 33186459
    [No Abstract]   [Full Text] [Related]  

  • 11. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium.
    Costa F; Brugaletta S
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):782-786. PubMed ID: 29705073
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic drugs.
    Med Lett Drugs Ther; 2014 Oct; 56(1454):103-9; quiz 1 p following 109. PubMed ID: 25337986
    [No Abstract]   [Full Text] [Related]  

  • 14. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic Therapy after Acute Coronary Syndromes.
    Bittl JA
    N Engl J Med; 2021 May; 384(19):1872-1873. PubMed ID: 33979502
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic Therapy after Acute Coronary Syndromes.
    Parada Barcia J; Raposeiras Roubin S; Abu-Assi E
    N Engl J Med; 2021 May; 384(19):1873. PubMed ID: 33979503
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction of haemorrhagic risk in acute coronary syndromes].
    Merino A; Roldán I; Marín F; Worner F;
    Med Clin (Barc); 2011 Nov; 137(14):650-5. PubMed ID: 20701931
    [No Abstract]   [Full Text] [Related]  

  • 19. The fading role of triple therapy in patients with atrial fibrillation and acute coronary syndrome: a Bayesian network meta-analysis.
    Osman M; Kheiri B; Munir MB; Moreland JA; Balla S; Kapadia S
    J Thromb Thrombolysis; 2019 Oct; 48(3):516-518. PubMed ID: 31175529
    [No Abstract]   [Full Text] [Related]  

  • 20. The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation.
    Hall TS; Atar D
    Eur J Intern Med; 2021 Jun; 88():21-22. PubMed ID: 33934970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.